Science Corporation’s vision‑restoring chip cleared for EU market

Science Corporation announced that its vision‑restoring chip has received regulatory approval in the European Union. The EU clearance permits the device to be marketed to individuals with vision loss. The chip is engineered to restore sight by interfacing with retinal tissue. European regulators reviewed the chip’s safety and efficacy before granting approval. Approval represents a key milestone for the company’s biotech development program. The decision enables the firm to begin commercial distribution within EU member states. The company said it will work with healthcare providers to launch the product. Industry observers will monitor adoption and potential expansion to other regions.